You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Drugs Containing Excipient (Inactive Ingredient) DIETHANOLAMINE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing DIETHANOLAMINE excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing DIETHANOLAMINE excipient

Market Dynamics and Financial Trajectory for Diethanolamine

Last updated: March 21, 2026

Diethanolamine (DEA) is an organic compound used primarily as an extractant, surfactant, neutralizer, and corrosion inhibitor in diverse industries. Its market prospects and financial trajectory are influenced by regulatory shifts, demand across industries, and supply chain developments.

Industry Applications and Demand Drivers

Personal Care and Cosmetics

Diethanolamine functions as an amphoteric surfactant and foam stabilizer in shampoos, body washes, and lotions. The rise in personal care products, especially in emerging markets, boosts DEA demand. The global cosmetics industry is projected to reach USD 430 billion by 2027, with a CAGR of 4.8% (Statista, 2023).

Paints and Coatings

DEA acts as a neutralizer and wetting agent. The global paints and coatings market, valued at USD 177 billion in 2022, grows at 4.2% annually (Research and Markets, 2023). The construction industry's resurgence fuels further demand.

Agrochemicals

In agrochemical manufacturing, DEA is used in herbicide formulations. The global agrochemicals market's CAGR is anticipated at 3.9% through 2028 (Grand View Research, 2023), indirectly bolstering DEA demand.

Detergents and Cleaning Agents

DEA is a key ingredient in cleaning formulations. The expanding household and industrial cleaning sectors propel this segment.

Organic Synthesis

DEA is involved in producing surfactants and corrosion inhibitors, especially in the oil and gas industry, which sees fluctuating demand based on global energy markets.

Regulatory and Environmental Factors

  • The U.S. Food and Drug Administration and European regulators have raised concerns about DEA's carcinogenic potential, specifically its ability to form nitrosamines, which are carcinogenic compounds.
  • The European Union classified DEA as a Substance of Very High Concern (SVHC) in 2019 under REACH regulations.
  • These regulatory pressures lead to stricter limits and push the industry toward alternative chemicals, potentially constraining future demand.

Supply Landscape

Major producers include:

Company Production Capacity Geographic Presence
BASF Extensive Europe, North America
Ashland Global Moderate North America, Europe
Solvay Moderate Europe, North America

Supply chain disruptions caused by COVID-19 and geopolitical tensions (e.g., China-U.S. trade issues) influence prices and availability.

Pricing Trends

Prices of DEA have experienced volatility:

  • 2020: Prices declined by 15%, attributed to oversupply and regulatory uncertainties.
  • 2021-2022: Prices recovered by approximately 20%, driven by supply constraints and increasing demand.
  • 2023: Prices stabilized but remained sensitive to regulatory actions, with regional disparities.

Financial Trajectory

Revenue and Market Size

The global market for diethanolamine was valued at approximately USD 300 million in 2022. Expected CAGR of 3.5% through 2028 (Research and Markets, 2023).

Key Factors Affecting Financial Performance

  • Regulatory restrictions reducing application scope.
  • Growing demand in emerging markets for personal care.
  • Technological innovations leading to alternative excipients.
  • Price volatility affecting margins.

Investment considerations

  • Companies focusing on R&D to develop safer, compliant substitutes.
  • Mergers and acquisitions as strategies to secure supply chains.
  • Companies with diversified applications and regional distribution are better positioned for growth.

Market Challenges and Opportunities

Challenges Opportunities
Regulatory restrictions on DEA use Investment in alternative compounds
Price volatility due to supply constraints Expanding application in growing markets
Environmental concerns leading to legislation Diversification into new excipient markets

Key Takeaways

  • Demand is driven mainly by growing personal care, coatings, and agrochemical sectors, with a CAGR of approximately 3.5% between 2022-2028.
  • Regulatory pressures pose a significant risk, prompting shifts toward safer alternatives.
  • Pricing volatility results from supply chain disruptions and changing regulations.
  • Suppliers like BASF and Ashland dominate the market but face challenges from environmental legislation.
  • Financial outlook remains cautiously optimistic for established players, contingent on innovation and compliance strategies.

FAQs

What are the primary uses of diethanolamine?
DEA is used as an emulsifier, foam stabilizer, neutralizer, and corrosion inhibitor across personal care, paints, agrochemicals, and cleaning products.

How do regulations impact DEA's market outlook?
Regulatory restrictions on carcinogenic potential, especially in the EU and the US, restrict application scope and pressure companies to seek alternatives, affecting future growth.

Which regions present the most growth opportunities for DEA?
Emerging markets in Asia-Pacific and Latin America exhibit higher demand growth owing to expanding personal care and industrial sectors.

What are the main supply risks facing the DEA market?
Supply constraints arise from geopolitical tensions, environmental legislation, and pandemic-related disruptions affecting manufacturing centers.

Can the DEA market sustain its current growth trajectory?
Yes, provided companies innovate with compliant alternatives and diversify applications, although growth may slow due to regulatory headwinds.


[1] Statista. (2023). Cosmetic industry worldwide revenue forecast. https://statista.com
[2] Research and Markets. (2023). Global paints and coatings market analysis. https://researchandmarkets.com
[3] Grand View Research. (2023). Agrochemicals market size and forecast. https://grandviewresearch.com

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.